Navidea Biopharmaceuticals, Inc. (NAVB)
OTCMKTS: NAVB · Delayed Price · USD
0.0010
0.00 (0.00%)
Jul 25, 2024, 4:00 PM EDT - Market closed
NAVB Employees
As of December 31, 2022, Navidea Biopharmaceuticals had 15 total employees, including 11 full-time and 4 part-time employees. The number of employees did not change compared to the previous year.
Employees
15
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$41
Profits / Employee
-$169,168
Market Cap
100.08K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
NAVB News
- 23 days ago - Navidea Biopharmaceuticals, Inc. Announces Results of Exploratory Analysis Completed on July 2, 2024 - Business Wire
- 5 weeks ago - Navidea Biopharmaceuticals, Inc. announces special meeting of stockholders to be held July 8, 2024 - Business Wire
- 6 months ago - Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations - Business Wire
- 8 months ago - Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release - Business Wire
- 10 months ago - Navidea Biopharmaceuticals, Inc. Announces NYSE American's Decision to Suspend Trading In Its Common Stock - Business Wire
- 10 months ago - NYSE American to Suspend Trading in Navidea Biopharmaceuticals, Inc. (NAVB) - Business Wire
- 1 year ago - Navidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing Panel - Business Wire
- 1 year ago - Navidea Biopharmaceuticals, Inc. Presses Ahead, Embraces Opportunities - Business Wire